
Determinants of Re Bleeding and Mortality in Cirrhotic Patients after Variceal Bleeding Approximately 50% of patients with cirrhosis have gastroesophageal varices and variceal bleeding (VB) from varices occurs in 30% of those patients. The rate of bleeding with known varices is 12 to 15% per year and VB is only 5–11% of all gastrointestinal bleeding1,2 but it is 60–65% of bleeding episodes in cirrhotic patients. Baveno VI consensus conference3 recommended following hemodynamic resuscitation, endoscopic variceal ligation or tissue adhesive should be undergone within 12h of presentation and vasoactive drugs should be started as soon as possible, before endoscopy. Antibiotic prophylaxis is an integral part of therapy for cirrhotic patients presenting with upper gastrointestinal bleeding but it may be voided in CTP class A patients as very low risk of bacterial infection and mortality. Vasoactive drugs (terlipressin, somatostatin, octreotide) should be used in combination with endosc...